Thrombotic Microangiopathy Associated with Intravenous Injection of Opana ER: University Medical Center Case Series

Journal Title: Journal of Case Reports and Studies - Year 2014, Vol 2, Issue 1

Abstract

In response to the rapidly rising intravenous opioid abuse epidemic, the United States Food and Drug Administration is currently promoting the development of prescription opioid tablets that are specifically formulated to deter abuse. Opana ER (Endo Pharmaceuticals) recently underwent reformulation to include a crush-resistant coating. Only recently described, illicit intravenous injection of reformulated Opana ER is associated with a distinctive clinical syndrome of thrombotic microangiopathy. Ten patients with the appropriate history and presenting symptoms were identified within an 8 month interval (July 2012 through February 2013) at the University of Tennessee Medical Center (UTMC) Knoxville with ICD-9 code of 446.6 (thrombotic microangiopathy) by electronic search. Review of laboratory data, electronic medical records, blood product usage, and total hospital admission charges were compiled for these individual patients. We report the clinicopathologic findings and correlating laboratory data for a group of patients presenting with thrombotic microangiopathy and documented recent history of intravenous Opana ER injection. We also report the economic impact and effect on blood product utilization by this study group.

Authors and Affiliations

Christopher T. Clark

Keywords

Related Articles

Rupture of a Giant Caesarean Scar Endometriosis Nodule - A Case Report and Literature Review

Background: Abdominal wall endometriosis is a rare condition occurring after caesarean section. A small painful nodule or lump near post caesarean scar is the common presentation. Large size endometrial nodules in anteri...

Resolution of Complete Atrioventricular Block in a Patient with Severe Hypothyroidism

Causes for syncope are multifaceted. Hormonal etiology, specifically hypothyroidism, is associated with cardiac arrhythmias [1]. Sinus bradycardia, low voltage, nonspecific T-wave changes and dissociative atrioventricula...

Postoperative Chylothorax: Is Octreotide A Valid Therapy?

Chylothorax is an extremely rare and serious complication of cardiac surgery, with a poor outcome unless treated at the right time and in the right way. We report a case of a 76-year-old female who developed chylothorax...

Improvement of Bilateral Elevated Foveal Retinoschisis Following Sequential Vitrectomy with ILM Peel in a Patient with Enhanced S Cone Syndrome

Purpose: To report outcomes after vitrectomy with ILM peel for bilateral elevated foveoschisis in a patient with Goldmann-Favre syndrome. Methods: Vitrectomy with ILM peel was done for one then the other eye of a 19 year...

Spinal Cord Compression Due to Extramedullary Hematopoiesis in a 27-YearOld Man with Beta Thalassemia Intermedia: A Case Report

Background: Extramedullary hematopoiesis (EMH) occurs in approximately 15% of cases of thalassemia. Paraspinal mass of extramedullary hematopoiesis are a rare compensatory process in intermediate and severe thalassemia....

Download PDF file
  • EP ID EP582407
  • DOI 10.15744/2348-9820.1.401
  • Views 129
  • Downloads 0

How To Cite

Christopher T. Clark (2014). Thrombotic Microangiopathy Associated with Intravenous Injection of Opana ER: University Medical Center Case Series. Journal of Case Reports and Studies, 2(1), 1-5. https://europub.co.uk./articles/-A-582407